Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cipla Ltd. Capital/Financing Update 2025

May 19, 2025

59275_rns_2025-05-19_8cb7ec99-8263-42af-97a4-6a6ecabf310c.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [84 x 30] intentionally omitted <==

19[th] May, 2025

(1) BSE Limited (2) National Stock Exchange of India Limited Listing Department, Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA EQ

  • (3) SOCIETE DE LA BOURSE DE LUXEMBOURG

Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Acquisition of shares in AMPIN Energy C&I Eighteen Private Limited

Dear Sir/Madam,

Pursuant to the provisions of the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby notify that Jay Precision Pharmaceuticals Private Limited, subsidiary of the Company has entered into Share Purchase, Subscription and Shareholder’s Agreement (“SPSSA”) today to acquire 26% stake on a fully diluted basis in AMPIN Energy C&I Eighteen Private Limited, for setting up captive solar power project in Maharashtra. This in line with the commitment to enhance the share of renewable power source in its operation and to comply with regulatory requirement for being a ‘captive user’ under Indian electricity laws.

The details required to be disclosed under the Listing Regulations read with SEBI Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11[th] November 2024 on the captioned subject are enclosed to this letter.

Please take the above information on record.

Yours faithfully,

For Cipla Limited

RAJENDRA Digitally signed by RAJENDRA KUMAR CHOPRA KUMAR CHOPRA Date: 2025.05.19 23:23:52 +05'30'

Rajendra Chopra Company Secretary

Prepared by: Akshaya Kolvankar

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India P +91 22 41916000 F +91 22 41916120 W www.cipla.com E-mail [email protected] Corporate Identity Numbe r L24239MH1935PLC002380

==> picture [84 x 30] intentionally omitted <==

Annexure - I

Sr. No. Particulars Details
a) Name of the target entity, details in
brief such as size, turnover etc.;
Name of the target entity: AMPIN Energy C&I Eighteen
Private Limited
Brief Details: AMPIN Energy C&I Eighteen Private
Limited, currently a wholly owned subsidiary of AMPIN
C&I Private Limited, is a special purpose vehicle formed
for purpose of setting up captive solar power project in
Maharashtra.
Turnover: Nil as on 31stMarch 2025. (unaudited)
b) Whether the acquisition would fall
within related party transaction(s)
and
whether
the
promoter/
promoter group/ group companies
have any interest in the entity being
acquired? If yes, nature of interest
and details thereof and whether the
same is done at “arm’s length”;
Acquisition doesn’t fall within the purview of related
party transactions.
None of the promoter / promoter group / group
companies have any interest in the entity.
c) Industry to which the entity being
acquired belongs;
Generation and transmission of solar energy and other
sources of renewable energy.
d) Objects and effects of acquisition
(including
but
not
limited
to,
disclosure of reasons for acquisition
of target entity, if its business is
outside the main line of business of
the listed entity);
In line with Cipla’s commitment to enhance the share
of renewable power source in its operation and to
comply with regulatory requirement for being a captive
user under Indian electricity laws,Jay Precision
Pharmaceuticals Private Limited(a subsidiary of the
Company) will acquire 26% stake on fully diluted basis
inAMPIN Energy C&I Eighteen Private Limited.
e) Brief details of any governmental or
regulatory approvals required for the
acquisition;
Not Applicable
f) Indicative time-period for completion
of the acquisition;
Subscription to equity shares is expected to be
completed within 1 month from the date of the signing
of the transaction documents, or by such other date as
maybe mutually agreed between the parties.
g) Nature of consideration - whether
cash consideration or share swap and
details of the same;
Cash consideration

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India P +91 22 41916000 F +91 22 41916120 W www.cipla.com E-mail [email protected] Corporate Identity Numbe r L24239MH1935PLC002380

==> picture [84 x 30] intentionally omitted <==

h) Cost of acquisition or the price at
which the shares are acquired
Up to INR 1,46,40,000 towards the acquisition of 26%
stake on a fully diluted basis.
i) Percentage of shareholding / control
acquired and / or number of shares
acquired;
(i)
Purchase of equity shares -2,600 equity shares
of face value INR 10 each at par.
(ii)
Subscription of equity shares -14,61,400 of
equity share of face value INR 10 each at par.
Cipla’s stake inAMPIN Energy C&I Eighteen Private
Limitedwould be 26% on a fully diluted basis.
j) Brief background about the entity
acquired in terms of products/line of
business
acquired,
date
of
incorporation, history of last 3 years’
turnover, country in which the
acquired entity has presence and any
other significant information (in
brief)
AMPIN Energy C&I Eighteen Private Limitedwas
incorporated on 5thApril 2023 in India for engaging in
business of generating, producing, accumulating,
storing,
improving,
buying,
selling,
reselling,
transmitting, distributing, and supplying electrical
power generated using solar energy and other sources
of renewable energy and developing infrastructure
projects based on solar energy.
History of last 3 years turnover: Nil
Country: India

Cipla Ltd.

Regd. Office - Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400 013, India P +91 22 41916000 F +91 22 41916120 W www.cipla.com E-mail [email protected] Corporate Identity Numbe r L24239MH1935PLC002380